Establishes foundation for medical AI collaboration in Vietnam… accelerating local business expansion

[April 28, 2026] AITRICS, a medical artificial intelligence (AI) company, announced on April 28 that it has signed a memorandum of understanding (MOU) with the Department of Health of Hung Yen Province in Vietnam to strengthen education and academic cooperation in AI-powered healthcare management.

The signing ceremony took place on April 23 at the Korea-Vietnam Business Forum, which was held as part of President Lee Jae-myung’s economic delegation. Amid expanding economic cooperation between the two countries, AITRICS used its participation in the economic delegation as an opportunity to discuss potential collaboration in Korean medical AI technology with Vietnamese government officials and establish a foundation for medical AI cooperation.

Through this agreement, both parties plan to collaborate to enhance the use of AI in Vietnam’s healthcare settings and improve local medical services. AITRICS will work with the Department of Health of Hung Yen Province on initiatives including medical staff training, sharing of technical and clinical expertise through expert exchanges, and joint academic seminars. The company also plans to explore the applicability of its AI solutions in line with Vietnam’s local healthcare environment and regulatory framework.

With this MOU, AITRICS has secured a foundation for collaboration with Vietnam’s public healthcare sector. Going forward, the company plans to explore ways to expand the use of medical AI across hospitals under Hung Yen Province and gradually broaden the scope of cooperation, including by hosting an AI symposium within the year for Vietnamese medical professionals and key officials from the Ministry of Health.

Kwangjoon Kim, CEO of AITRICS, said, “Vietnam is a market with strong demand and significant growth potential for the adoption of medical AI. Through this agreement, we expect to establish a foundation for the use of medical AI in Vietnam and contribute to improving the quality of healthcare services.” He added, “Moving forward, we will continue to build cooperation models tailored to each local healthcare environment and strengthen our position as a global medical AI company.”

Meanwhile, AITRICS obtained medical device approval in Vietnam in October 2024 for its AI solution, AITRICS-VC, also known as VitalCare, which predicts patient deterioration. The company has also obtained regulatory approvals for VitalCare in five countries, including Korea, the United States, Vietnam, Indonesia, and Hong Kong, including FDA clearance in the U.S. AITRICS is continuing its global business expansion by pursuing additional regulatory approvals in Southeast Asian markets such as Singapore and Malaysia.